Company Overview - Rescued Pets Movement Inc. (RPM) is the largest homeless animal rescue, rehabilitation, and transport nonprofit in the United States, having saved approximately 92,000 homeless animals since its founding in September 2013 [1][10] - RPM focuses on rescuing at-risk pets from overcrowded shelters in the Houston area, providing veterinary care, and transporting them to regions with higher demand for adoptable pets [1][10] Recent Developments - RPM has been selected by Main Street Capital Corporation as its charity of choice for the NYSE's 2024 Global Giving Campaign, which will enhance RPM's operations and support its mission [6][7] - In 2024 alone, RPM has already rescued 7,350 animals, contributing to its total of approximately 92,000 rescues since inception [2][10] Partnership with Main Street Capital - Main Street Capital is committed to providing financial support and volunteer resources to RPM, aligning with its corporate social responsibility initiatives [7][8] - Main Street's employees are actively engaged in volunteer opportunities with RPM, assisting in various operations including animal care and community outreach [7][8] Mission and Impact - RPM aims to create a world where every animal is valued and loved, transforming the lives of countless animals through dedicated rescue efforts and transport initiatives [2][10] - The partnership with Main Street Capital allows RPM to expand its medical services, improve boarding facilities, and ensure safe transportation for the animals [2][7]

Core Viewpoint - PetMed Express, Inc. has adopted a limited duration shareholder rights plan to protect the interests of its shareholders during a period of significant stock accumulation by certain shareholders, believing that the current share price does not reflect the company's inherent value or long-term growth potential [1][2]. Summary by Sections Rights Plan Adoption - The Board of Directors has implemented a Rights Plan to enable shareholders to realize the long-term value of their investments and to prevent any entity from gaining control without compensating all shareholders appropriately [2][3]. Rights Plan Details - The Rights Plan will issue one right for each outstanding share of common stock to shareholders of record on December 16, 2024, and will be effective immediately, expiring on December 2, 2025, unless terminated earlier [5]. - Rights become exercisable if an acquiring person obtains 12.5% or more of the outstanding shares without Board approval, allowing existing right holders to purchase shares at a 50% discount [6]. Exemptions and Conditions - Existing shareholders who own 12.5% or more prior to the announcement of the Rights Plan will not face penalties as long as they do not increase their ownership [7]. - The Rights Plan does not interfere with any Board-approved sales, mergers, or other business combinations [4]. Company Overview - PetMed Express, Inc. is a leader in the consumer pet healthcare sector, providing a range of pharmaceuticals and health products for pets through its online platforms [9][10].

Group 1 - PetMed Express (NASDAQ: PETS) experienced a significant stock surge of approximately 35.8% on November 7 [1] - The surge in stock price is attributed to recent developments related to the online pet pharmacy [1] Group 2 - No specific financial metrics or future projections were provided in the article [2] - The article does not include any investment recommendations or advice [2] - The author has no financial interest in PetMed Express or any related companies mentioned [2]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Global Select Market FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ ...

PetMed Express, Inc. (NASDAQ:PETS) Q2 2025 Earnings Conference Call November 6, 2024 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR Sandra Campos - Chief Executive Officer and President Robyn D'Elia - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Operator Greetings and welcome to PetMed Express Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow ...

Financial Performance - PetMed (PETS) reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of a loss of $0.06 per share, compared to break-even earnings per share a year ago, representing an earnings surprise of 283.33% [1] - The company posted revenues of $59.57 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 9.77%, and down from $71 million in the same quarter last year [2] - PetMed has surpassed consensus EPS estimates two times over the last four quarters but has not beaten consensus revenue estimates during that period [2] Stock Performance - PetMed shares have declined approximately 43.6% since the beginning of the year, while the S&P 500 has gained 21.2% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $64.51 million, and for the current fiscal year, it is $0.08 on revenues of $265.56 million [7] - The estimate revisions trend for PetMed is currently favorable, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Internet - Commerce industry, to which PetMed belongs, is currently ranked in the top 27% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Chewy (CHWY), another company in the same industry, is expected to report quarterly earnings of $0.23 per share, reflecting a year-over-year increase of 53.3% [9]

Financial Performance - Net sales for Q2 FY2025 were $59.6 million, a decrease from $70.999 million in the same period last year[2] - Gross margin improved to 29.1%, up 0.8% compared to the prior year period[2] - Net income increased to $2.3 million, or $0.11 per diluted share, compared to $0.7 million, or $0.03 per diluted share, in the prior year[2] - Net income for the six months ended September 30, 2024, was $6,080,000, a significant increase of 1,544% compared to a net loss of $421,000 in the same period of 2023[19] - Adjusted EBITDA was $2.1 million, a significant improvement from an Adjusted EBITDA loss of $(1.5) million in Q1 FY2025[3] - Adjusted EBITDA for the six months ended September 30, 2024, was $561,000, a decrease of 92% from $6,772,000 in the prior year[19] Operating Expenses and Liabilities - Operating expenses decreased to $16.757 million from $19.187 million in the prior year period, reflecting cost control measures[11] - Total current liabilities reduced to $48.832 million from $72.158 million at the end of the previous fiscal year[10] Cash Flow and Cash Position - Cash and cash equivalents were $52.045 million, down from $55.296 million at the end of the previous fiscal year[10] - Cash flows from operating activities showed a net cash used of $1,128,000 for the six months ended September 30, 2024, compared to a net cash used of $215,000 in 2023[12] - Cash and cash equivalents at the end of the period were $52,045,000, down from $53,471,000 at the end of the previous year[12] - The company reported a net decrease in cash and cash equivalents of $3,251,000 for the six months ended September 30, 2024, compared to a decrease of $50,615,000 in the same period of 2023[12] Inventory and Accounts Receivable - The company reported a significant increase in inventories, netting $15,464,000 for the six months ended September 30, 2024, compared to $3,237,000 in 2023[12] - Accounts receivable increased by $1,488,000 for the six months ended September 30, 2024, compared to a decrease of $345,000 in 2023[12] Strategic Initiatives - The company is focused on consolidating operations to lower costs and improve profitability as part of its transformation strategy[4] - Future growth initiatives will include differentiating product assortments and enhancing brand awareness campaigns[4] - The company remains confident in its turnaround strategy and the investments being made to strengthen its competitive position[4] Stock-Based Compensation and Dividends - Stock-based compensation for the six months ended September 30, 2024, was $(7,631,000), a decrease of 319% from $3,488,000 in the same period of 2023[19] - The company paid dividends of $175,000 in the current period, a significant decrease from $12,404,000 in the same period of 2023[12] Acquisitions - The company acquired PetCareRx, resulting in a cash outflow of $35,859,000 in the previous period[12]

DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of $59.6 million.Gross margin of 29.1%, an increase of 0.8% compared to the prior year period.Net income of $2.3 million, or $0.11 per diluted share, compared to net income of $0.7 million, or $0.03 per diluted share, in the prior ye ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks St ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks St ...